MDGL
$499.40-0.06%
as of close, Oct 2, 2026
☾ AH $499.40 -0.06%
Madrigal Pharmaceuticals Inc.Stock · Health CareNasdaq Composite 0.02%Russell 1000 0.01%US Stock Market 0.01%Russell 3000 0.01%
Madrigal Pharmaceuticals Inc. returns by year
As of market close, Oct 2, 2026
Madrigal Pharmaceuticals Inc. returns by year (2008–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $582.34 | $499.40 | 0.0% | -14.2% | |
| 2025 | $308.57 | $582.34 | 0.0% | +88.7% | |
| 2024 | $231.38 | $308.57 | 0.0% | +33.4% | |
| 2023 | $290.25 | $231.38 | 0.0% | -20.3% | |
| 2022 | $84.74 | $290.25 | 0.0% | +242.5% | |
| 2021 | $111.17 | $84.74 | 0.0% | -23.8% | |
| 2020 | $91.11 | $111.17 | 0.0% | +22.0% | |
| 2019 | $112.72 | $91.11 | 0.0% | -19.2% | |
| 2018 | $91.79 | $112.72 | 0.0% | +22.8% | |
| 2017 | $14.90 | $91.79 | 0.0% | +516.0% | |
| 2016 | $12.25 | $14.90 | 0.0% | +21.6% | |
| 2015 | $92.75 | $12.25 | 0.0% | -86.8% | |
| 2014 | $183.40 | $92.75 | 0.0% | -49.4% | |
| 2013 | $315.70 | $183.40 | 0.0% | -41.9% | |
| 2012 | $163.45 | $315.70 | 0.0% | +93.1% | |
| 2011 | $214.20 | $163.45 | 0.0% | -23.7% | |
| 2010 | $177.10 | $214.20 | 0.0% | +20.9% | |
| 2009 | $214.20 | $177.10 | 0.0% | -17.3% | |
| 2008 | $234.50 | $214.20 | 0.0% | -8.7% |
- Annualized
- +2.7%
- 2008–2026
- Average year
- +42.8%
- 18 full years
- Best year
- +516.0%
- 2017
- Worst year
- -86.8%
- 2015
- Positive years
- 9/18
- 50% up
Annualized (CAGR)
+2.7%
2008–2026
Average year
+42.8%
18 full years
Best year
+516.0%
2017
Worst year
-86.8%
2015
Positive years
9/18
50% up
Total return by period#
Annual
-400%-200%0%200%400%
2008-8.7%'08
2009-17%
2010+21%'10
2011-24%
2012+93%'12
2013-42%
2014-49%'14
2015-87%
2016+22%'16
2017+516%
2018+23%'18
2019-19%
2020+22%'20
2021-24%
2022+243%'22
2023-20%
2024+33%'24
2025+89%
2026-14%'26
Methodology#
Total returns, dividends reinvested, measured on MDGL. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Madrigal Pharmaceuticals Inc.'s average annual return?
- Since 2008, Madrigal Pharmaceuticals Inc. (MDGL) has returned about 2.7% a year (the compound annual growth rate) and an average calendar-year return of 42.8%.
- What were Madrigal Pharmaceuticals Inc.'s best and worst years?
- Over 2008–2026, the best year was 2017 (+516.0%) and the worst was 2015 (-86.8%).
- How often is Madrigal Pharmaceuticals Inc. up in a year?
- 9 of the 18 full years since 2008 were positive — about 50% of the time.
More on Madrigal Pharmaceuticals Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100